| Name |
Treprostinil (JAN/USAN/INN);Remodulin (TN) |
| Product |
TREPROSTINIL (United Therapeutics Corporation), TYVASO (United Therapeutics Corporation), TYVASO DPI (United Therapeutics Corporation) |
| Generic |
TREPROSTINIL (Alembic Pharmaceuticals), TREPROSTINIL (Endo USA), TREPROSTINIL (Sandoz), TREPROSTINIL (Teva Parenteral Medicines), WATER (Dr.Reddy's Laboratories Inc.,) |
| Formula |
C23H34O5 |
| Exact mass |
390.2406 |
| Mol weight |
390.51 |
| Structure |
 |
| Simcomp |
|
| Class |
Blood modifier agent DG01950 Antithrombotic agent DG01712 Antiplatelet agentHormonal agent DG01961 Prostaglandin derivative DG01810 Prostacycline derivativeMetabolizing enzyme substrate DG02918 CYP2C8 substrate |
| Remark |
Therapeutic category: 2190ATC code: B01AC21Chemical structure group: DG00161Product (DG00161): D06213<JP/US> D10430<US> |
| Efficacy |
Anticoagulant, Antihypertensive, Vasodilator, Platelet aggregation inhibitor, Prostaglandin I2 receptor agonist |
| Disease |
Pulmonary arterial hypertension [DS:H01621] |
| Comment |
Prostacycline derivative |
| Target |
PTGIR [HSA:5739] [KO:K04263] |
| Pathway |
hsa04080 Neuroactive ligand-receptor interactionhsa04270 Vascular smooth muscle contractionhsa04611 Platelet activation |
| Metabolism |
Enzyme: CYP2C8 [HSA:1558] |
| Interaction |
|
| Structure map |
map07228 Eicosanoid receptor agonists/antagonists |
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303] B BLOOD AND BLOOD FORMING ORGANS B01 ANTITHROMBOTIC AGENTS B01A ANTITHROMBOTIC AGENTS B01AC Platelet aggregation inhibitors excl. heparin B01AC21 Treprostinil D06213 Treprostinil (JAN/USAN/INN) <JP/US>USP drug classification [BR:br08302] Respiratory Tract/Pulmonary Agents Pulmonary Antihypertensives Prostacyclin Vasodilators Treprostinil D06213 Treprostinil (JAN/USAN/INN)Therapeutic category of drugs in Japan [BR:br08301] 2 Agents affecting individual organs 21 Cardiovascular agents 219 Miscellaneous 2190 Miscellaneous D06213 Treprostinil (JAN/USAN/INN)Drug groups [BR:br08330] Blood modifier agent DG01950 Antithrombotic agent DG01712 Antiplatelet agent DG00161 Treprostinil D06213 Treprostinil Hormonal agent DG01961 Prostaglandin derivative DG01810 Prostacycline derivative DG00161 Treprostinil D06213 Treprostinil Metabolizing enzyme substrate DG02918 CYP2C8 substrate DG00161 Treprostinil D06213 TreprostinilTarget-based classification of drugs [BR:br08310] G Protein-coupled receptors Rhodopsin family Prostacyclin PTGIR D06213 Treprostinil (JAN/USAN/INN) <JP/US>New drug approvals in the USA [br08319.html] New molecular entities and new therapeutic biological products D06213New drug approvals in Japan [br08318.html] Drugs with new active ingredients D06213New drug approvals in the USA, Europe and Japan [br08328.html] Approval dates by FDA, EMA and PMDA D06213Drug metabolizing enzymes and transporters [br08309.html] Drug metabolizing enzymes D06213Drug groups [BR:br08330] Blood modifier agent DG01950 Antithrombotic agent DG01712 Antiplatelet agent DG00161 Treprostinil Hormonal agent DG01961 Prostaglandin derivative DG01810 Prostacycline derivative DG00161 Treprostinil Metabolizing enzyme substrate DG02918 CYP2C8 substrate DG00161 Treprostinil |
| Other DBs |
CAS: 81846-19-7PubChem: 47207871ChEBI: 50861PDB-CCD: Y9J[PDBj] LigandBox: D06213NIKKAJI: J430.982K |
| LinkDB |
|
| KCF data |
ATOM 28 1 C1x C 18.2700 -24.7100 2 C1y C 19.0400 -25.9000 3 C1y C 20.3700 -25.4800 4 C1y C 20.3700 -24.0800 5 C1y C 19.0400 -23.5900 6 C1b C 21.5600 -26.1800 7 C1b C 22.7500 -25.4800 8 C1c C 23.9400 -26.1800 9 C1b C 25.1300 -25.4800 10 O1a O 23.9400 -27.5800 11 C1b C 26.3200 -26.1800 12 C1b C 27.5100 -25.4800 13 C1b C 28.7000 -26.1800 14 C1a C 29.8900 -25.4800 15 O1a O 18.5500 -27.2300 16 C1x C 21.4200 -23.1700 17 C8y C 21.2100 -21.7700 18 C8y C 19.8800 -21.2800 19 C1x C 18.8300 -22.1900 20 C8x C 22.2600 -20.9300 21 C8x C 22.0500 -19.5300 22 C8x C 20.7200 -19.0400 23 C8y C 19.6700 -19.9500 24 O2a O 18.4800 -19.2500 25 C1b C 17.2900 -19.9500 26 C6a C 16.1000 -19.2500 27 O6a O 14.9100 -19.9500 28 O6a O 16.1000 -17.8500BOND 30 1 1 2 1 2 2 3 1 3 3 4 1 4 4 5 1 5 1 5 1 6 3 6 1 #Up 7 6 7 1 8 7 8 1 9 8 9 1 10 8 10 1 #Down 11 9 11 1 12 11 12 1 13 12 13 1 14 13 14 1 15 2 15 1 #Down 16 4 16 1 #Down 17 16 17 1 18 17 18 1 19 18 19 1 20 5 19 1 #Down 21 17 20 2 22 20 21 1 23 21 22 2 24 22 23 1 25 18 23 2 26 24 23 1 27 24 25 1 28 25 26 1 29 26 27 1 30 26 28 2 |
